Ardent Health (ARDT) Common Equity (2022 - 2026)

Ardent Health has reported Common Equity for 5 years, with the latest figure at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 14.56% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 14.56% YoY), and the FY2025 full-year result was $1.7 billion, up 10.85% from the prior year.
• Common Equity for Q1 2026 stood at $1.3 billion, down from $1.7 billion in the prior quarter.
• The five-year high for Common Equity was $1.7 billion in Q4 2025, with the low at $1.0 billion in Q4 2022.
• Average Common Equity over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2025.
• Year-over-year, Common Equity soared 42.2% in 2025 and declined 14.56% in 2026.
• Tracing ARDT's Common Equity over 5 years: stood at $1.0 billion in 2022, then gained by 3.42% to $1.1 billion in 2023, then jumped by 41.51% to $1.5 billion in 2024, then gained by 10.85% to $1.7 billion in 2025, then dropped by 20.72% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison